Name: Key Takeaways and Recordings from IBS Myths and Misconceptions Webinar Series | Commonwealth Diagnostics International
Uploaded: 2021-04-20 16:16:16
Duration: 3776 s
Description: CDI and MyGiHealth were proud to join World IBS Day, Rome Foundation, and an esteemed panel of IBS experts to dispel myths and misconceptions of IBS during

CDI and MyGiHealth were proud to join World IBS Day, Rome Foundation, and an esteemed panel of IBS experts to dispel myths and misconceptions of IBS during two live virtual interactive sessions for patients and providers held on April 19 (World IBS Day) and April 26.

The esteemed faculty panel included:

William Chey, MD, Gastroenterologist, Director and Professor at Michigan Medicine’s Division of Gastroenterology
Laurie Keefer, PhD, Director for Psychobehavioral Research within the Division of Gastroenterology at Mount Sinai and Chair of Rome Foundation’s GastroPsych Group
Kate Scarlata, RDN, LDN, Nutrition Consultant and Best-Selling Author

Both sessions were moderated by:

Johannah Ruddy, M.Ed., national expert, academic researcher and writer, and Executive Director of the Rome Foundation
Jeffrey Roberts, M.Ed., IBS patient for 25+ years, founder of the IBS Patient Support Group, and World IBS Day coordinator

Recordings for both sessions are now available as well as additional resources to allow both patients and providers to continue learning about the diagnosis, treatment, and management of IBS.

Key Takeaways from our Faculty Panel

“Multi-disciplinary team-based care can be the key to success!” Our well-rounded panelists agree that taking an integrated care approach to the diagnosis and treatment of IBS can provide better results for patients and that patients value a cohesive care plan.
“Doing a hydrogen & methane breath test is valuable in terms of making a precise diagnosis of bacterial overgrowth, and it’s been shown in a number of studies that IBS patients with a positive breath test for bacterial overgrowth are the patients that are most likely to respond to a course of antibiotic treatment.” – Dr. William Chey
“The Rome IV criteria reinforces the notion that IBS is a symptom-based condition” – Dr. William Chey
Telehealth and digital communication are valuable to help communication flowing between the patient and provider. This also helps the patient feels supported in between in-person visits.
There is a lot of exciting, new science and research circulating regarding new treatments available for IBS.